Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biotechnology Journal"
DOI: 10.1002/biot.202100266
Abstract: The production of biopharmaceuticals in engineered plant‐based systems is a promising technology that has proven its suitability for the production of various recombinant glyco–proteins that are currently undergoing clinical trials. However, compared to mammalian cell…
read more here.
Keywords:
broadly neutralizing;
human broadly;
neutralizing anti;
anti hiv ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biotechnology Progress"
DOI: 10.1002/btpr.3296
Abstract: Broadly neutralizing antibody (bNAb) CAP256‐VRC26.25 (abbreviated CAP256LS), a human IgGI monoclonal antibody targeting the V1V2 site of the HIV‐1 envelope, has demonstrated high therapeutic potential as a broadly neutralizing monoclonal antibody against HIV‐1. During the…
read more here.
Keywords:
heavy chain;
analytical characterization;
broadly neutralizing;
development ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28106
Abstract: The discovery of broadly neutralizing monoclonal antibodies against influenza viruses has raised hope for the successful development of new antiviral drugs. However, due to the speed and variety of mutations in influenza viruses, single‐component antibodies…
read more here.
Keywords:
antibodies recognizing;
different antigenic;
broadly neutralizing;
recognizing different ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Current topics in microbiology and immunology"
DOI: 10.1007/82_2020_221
Abstract: Development of vaccines to highly variable viruses such as Human Immunodeficiency Virus and influenza A viruses faces multiple challenges. In this article, these challenges are described and reverse vaccinology approaches to generate universal vaccines against…
read more here.
Keywords:
antigenically variable;
variable viruses;
antibodies highly;
highly antigenically ... See more keywords
Photo by kwook from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "Archives of Virology"
DOI: 10.1007/s00705-018-4011-7
Abstract: Broadly neutralizing antibodies (bNAbs) are very promising agents for HIV-1 prophylaxis and AIDS treatment. However, the neutralization susceptibility of circulating recombinants such as CRF01_AE, which is becoming increasingly prevalent, has not been studied in detail…
read more here.
Keywords:
susceptibility;
neutralizing antibodies;
pg9 pg16;
evaluation susceptibility ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cell Reports"
DOI: 10.1016/j.celrep.2018.04.101
Abstract: Summary Human high-affinity antibodies to pathogens often recognize unrelated ligands. The molecular origin and the role of this polyreactivity are largely unknown. Here, we report that HIV-1 broadly neutralizing antibodies (bNAbs) are frequently polyreactive, cross-reacting…
read more here.
Keywords:
conformational plasticity;
non hiv;
hiv;
polyreactivity ... See more keywords
Photo from academic.microsoft.com
Sign Up to like & get
recommendations!
0
Published in 2019 at "Current opinion in virology"
DOI: 10.1016/j.coviro.2019.02.004
Abstract: Broadly neutralizing antibodies (bnAbs) are potential therapeutic molecules and valuable tools for studying conserved viral targets for vaccine and drug design. Interestingly, antibody responses to conserved epitopes can be highly convergent at the molecular level.…
read more here.
Keywords:
genetics;
neutralizing antibodies;
vh1 antiviral;
antiviral broadly ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2017 at "Immunity"
DOI: 10.1016/j.immuni.2017.03.017
Abstract: &NA; Broadly neutralizing antibodies (bnAbs) to HIV delineate vaccine targets and are prophylactic and therapeutic agents. Some of the most potent bnAbs target a quaternary epitope at the apex of the surface HIV envelope (Env)…
read more here.
Keywords:
apex;
antibody;
structure;
broadly neutralizing ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Immunity"
DOI: 10.1016/j.immuni.2017.11.002
Abstract: SUMMARY Understanding how broadly neutralizing antibodies (bnAbs) to HIV envelope (Env) develop during natural infection can help guide the rational design of an HIV vaccine. Here, we described a bnAb lineage targeting the Env V2…
read more here.
Keywords:
lineage;
heterogeneity;
env;
glycoform heterogeneity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Immunity"
DOI: 10.1016/j.immuni.2019.10.008
Abstract: Summary The elicitation of broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) trimer remains a major vaccine challenge. Most cross-conserved protein determinants are occluded by self-N-glycan shielding, limiting B cell recognition of the…
read more here.
Keywords:
envelope;
trimer;
neutralizing antibodies;
vaccination glycan ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of molecular biology"
DOI: 10.1016/j.jmb.2017.03.008
Abstract: The exceptional breadth of broadly neutralizing antibodies (bNAbs) against the membrane-proximal external region (MPER) of the transmembrane protein gp41 makes this class of antibodies an ideal model to design HIV vaccines. From a practical point…
read more here.
Keywords:
antibody;
apex region;
anti hiv;
membrane ... See more keywords